Introduction
Infective endocarditis (IE) remains a deadly disease despite continuous advances in medical and surgical management [1] [2] [3] 4 ••]. In the recent years, epidemiology of IE has undergone significant changes with increasing number of elderly patients presenting with degenerative valvular disease, nosocomial infections, or device-related IE (prosthetic valves (PV), cardiac implantable electronic devices (CIED)). Though the diagnosis of IE remains challenging, the main advantage of timely diagnosis is the potential to prevent complications such as embolic events, septic complications, and valvular destruction [1] . In daily practice, the diagnosis of IE relies on the modified Duke criteria that use typical clinical signs and symptoms and positive blood cultures to reach a definitive diagnosis when the valve/device can be shown to be affected on echocardiography (vegetation, abscess or pseudoaneurysm, and new PV dehiscence). However, this technique has a sensitivity and specificity of approximately 80% for native valve endocarditis (NVE) [2] . The diagnostic accuracy is even lower for PVE [3] or CIED infection [4••] , in which echocardiography gives uncertain results in up to 30% of cases. The major drawbacks of transthoracic (TTE) and transoesophageal (TOE) echocardiography are related to patient morphology, instrumental settings, transducer position, operator skill, artefacts secondary to calcifications and reverberations of This article is part of the Topical Collection on Cardiac Nuclear Imaging metallic structures, and the disease course (less accurate in the early stage) [5] . The shortcomings of the diagnosis of IE based on morphological changes have triggered an increasing use of functional imaging ( 
]FDG) positron emission tomography (PET) and radiolabelled leukocytes single-photon emission computed tomography (SPECT)) for the evaluation of the metabolic activity caused by the infection, prior to any structural (morphological) change. When combined with standard diagnostic tests, functional imaging procedures have been shown to reduce the rate of misdiagnosed cases of IE. The recent European Society of Cardiology (ESC) guidelines have incorporated molecular imaging in the diagnostic work-up of PVE, whereas in case of CIED infection, the indication is less supported by the literature (recommendation class IIB level of evidence C) [1] . According to the new guidelines, the finding of abnormal [ 18 F]FDG or radiolabelled leukocyte uptake around PV represents a major Duke criterion, whilst an embolic event or infectious aneurysms detected by imaging represents a minor criterion. All this has highlighted the major role of the imaging specialists as part of the 'Endocarditis Team', in the management of IE. In the present article, we summarized the available evidence for the use of nuclear imaging for the evaluation of IE. 18 F]FDG PET and high-resolution computed tomography (CT), the functional information and the anatomical details are entailed in single image [7] . Wholebody PET/CT is performed using a single acquisition time-point, generally 45-60 min after intravenous injection of [ 18 F]FDG, with an emission time/bed position depending on the sensitivity of the scanner. The field of acquisition is usually derived from oncology studies from skull base to mid thighs. The majority of PET/CT studies consists of a protocol comprising a scanogram/scout scan/topogram and CT-AC. The simultaneous acquisition of a standard diagnostic CT scan with intravenous contrast agent is possible. PET images are visually evaluated to search for area of increased [ 18 F]FDG uptake, taking into consideration the pattern (focal, linear, diffuse), intensity, and relationship to areas of physiologic distribution. PET information is compared with morphologic information obtained by CT. Semi-quantitative analysis by maximal standardized uptake value (SUVmax) or other semiquantitative parameters is also possible. However, SUV has not been validated in infection [8• In-oxine-WBC. A SPECT/CT acquisition is mandatory as part of the standard imaging protocol, and it is usually acquired at 4-6 h and/or at 20-24 h p.i.
99m Tc-HMPAO is preferred because more available, provides better image quality with lower patients radiation burden [6, 10•] . The interpretation of WBC scintigraphy should always begin with a visual quality control performed on WB images and chest planar acquisitions. The signal kinetics between 4 and 6 h and 20-24 h acquisitions is an important feature for interpretation: any stable-increased uptake intensity or size over time, confirmed at SPECT/ CT, is highly suggestive of infection (Table 1) .
Native Valve Endocarditis
In native valve endocarditis (NVE), the usefulness of functional nuclear imaging has yet to be demonstrated. Indeed, few studies evaluated this specific clinical setting. In a recent prospective study concerning 72 patients with bacteraemia (Staphylococcus, Streptococcus species and Enterococcus species), Kouijzer et al. reported a limited accuracy (sensitivity 39%, specificity was 93%) of [ 18 F]FDG PET/CT for diagnosing IE. Only two patients had PV in this study [11••] . Other smaller studies did not show better results [12••] (Table 2) . Nevertheless, this technique may allow early detection of metastatic infectious disease with a high sensitivity (87-100%) and specificity (80%) [12••] , at a reasonable cost-effectiveness, especially in patients with Grampositive bacteraemia [13•] .
99m TC-HMPAO WBC SPECT/CT has been used by Erba et al. in a mixed population (16 NVE and 35 PVE) showing that no cases were undiagnosed when either the echography or the blood cultures were positive [14••] (Table 2) (Fig. 1 ).
Prosthetic Valve Endocarditis
The rate of prosthetic valve endocarditis (PVE) ranges from 1-6 to 15%, being higher in revision surgery [15] . Conversely to NVE, which is usually limited to the presence of a vegetation, PVE infection generally spread along the sewing ring and leads to peri-annular extension (pseudo-aneurysms, abscess) [16] . In a recent prospective study concerning 72 patients, Saby et al. showed that adding abnormal 18 F-FDG uptake around a PV to the modified Duke criteria at admission increased the sensitivity for definite PVE from 70 to 97% (Table 2 ) [17••] . This result was due to a significant reduction in the number of possible PVE cases from 56 to 32%. In addition, [ 18 F]FDG PET/CT allowed detection of valvular damage before ultrasounds [8, 18] . Other smaller studies also confirmed these data [12] . (Table 2) . Besides, [ 18 F]FDG PET/CTA identified a greater number of anatomic lesions than PET/CT or echocardiography, many of them relevant for clinical and surgical decision-making (pseudoaneurysms, fistulas, thrombosis and coronary involvement) [18] .
A clear advantage of CTA in IE patients is the ability to assess the entire chest (identification of septic pulmonary infarcts and abscesses), the aorta and the coronary arteries before contemplated surgery [18••] . Several reports have also highlighted the potential added value of radiolabelled leukocytes SPECT/CT in the diagnosis of PVE (sensitivity 64-90%, specificity 36-100%), even in the early post-intervention phase [14, 19•] . As for [ Tc-WBC SPECT/CT has an excellent positive predictive value for the detection of perivalvular infection and abscesses in patients with a suspicion of PVE. In addition, the intensity of radiolabelled leucocyte accumulation in the perivalvular area detected with scintigraphy represents an interesting marker of local infectious activity and extension. Patients (Fig. 2) .
Cardiac Device-Related IE
Cardiac device-related IE (CDRIE)-infection extending to the electrode leads, cardiac valve leaflets, or endocardial surfaceshould be distinguished from local device infection (pocket/generator). An incidence of 1.4 per 1000 device-years of definite CDRIE has been reported [3] . As for PV, 99m
Tc-WBC SPECT/ CT and [ 18 F]FDG PET/CT are able to differentiate CDRIE from post-implantation changes (i.e., pocket hematoma) and to characterize the extension of the infectious process (Fig. 3) . [12] . Such a finding is mainly related to the small size of the vegetations along the leads, which are often under the spatial resolution of the system [20] . [ limited to the pocket or leads from a more severe infection affecting the whole device [23] (Table 2) . Therefore, both imaging approaches can be of help in patients with suspected CDRIE (ESC class IIb recommendations) [5] .
Detection of Metastatic Infectious Events
Embolic events are a frequent and life-threatening complication of IE. They occur in 20-50% of patients and can be totally silent in 20-50% of cases. The brain and spleen are the most affected in the left IE while the lungs complicate the right IE, particularly in CDRIE [5] . In the recent ESC guidelines, the imaging detection of septic emboli clearly impacts on the Duke score and consequently on the diagnostic certainty of IE (minor criterion) and decision-making. In fact, as reported by several authors, [ 18 F]FDG PET/CT is capable of detecting distant embolic sites (15%) with a reasonable sensitivity (14-100%) and specificity (80%), most of which clinically silent (up to 30%), and previously undiagnosed tumours (6.5%), many of them in early stages and potentially curable [12, 24] . This approach is relatively costeffective and may avoid using additional ionizing radiologic techniques. [ 18 F]FDG PET/CT is very accurate in organs with low physiological uptake, therefore not applicable in ruling out the presence of brain embolism [25•] . Radiolabelled leukocytes SPECT/CT shares with PET/CT the possibility of acquiring whole-body images and by performing additional planar and SPECT/CT spot images also constitutes an invaluable aid for detecting septic embolism even in asymptomatic patients [14, 23•] .
Left Ventricular Assist Device Associated Infections
The prevalence of infection and sepsis in left ventricular assist device (LVAD) patients ranges from 23 to 58%, being associated with a high mortality rate (15-44%) [26] . The major sites of infection comprise the mediastinum drivelines and device surface, so called « LVAD endocarditis » [27] . In a recent retrospective study concerning 31 patients, [
18 F]FDG PET/CT yielded a sensitivity of 100% and a specificity of 94% for the diagnosis of LVAD infection [28] . Litzler et al. also highlighted the potential usefulness of radiolabelled leukocytes SPECT/CT in the management of LVAD infection (8 patients) by determining the precise anatomic location and extent of a suspected infection [26] . The evidence in this setting is, however, still quite limited.
Limitations and Technical Considerations
Despite significant advantages, molecular imaging techniques still present limitations that would require further developments ( Table 1 ). The majority of them are related to the complexity of imaging interpretation, particularly when [ 18 F]FDG is used. In fact, several pathological conditions can mimick the pattern of focally increased uptake such as non-infected tissue (active thrombi, atherosclerotic plaques, vasculitis, tumours, lipomatous hypertrophy of the inter-atrial septum, foreign body reactions (i.e. BioGlue surgical adhesive used to seal the aortic graft at time of surgery)). Timing of imaging in relation to surgical intervention still remains an open issue since up to 4-8 weeks, the persistence of post-operative inflammatory response with false positive results is possible. Clear definition of the impact of antimicrobial treatment (risk of false negative cases) as well as of blurring artefacts has also to be established. In addition, the problem of false negative results in presence of small oscillating vegetation and metastatic foci <5 mm which are below the threshold of detectability/resolution has to be considered as well as the issue of radiation burden that might increase when certain protocol for imaging acquisition are applied (i.e. retrospective ECG-triggering) [6, 29] .
The best strategy to reduce false positive finding is correct patient preparation and selection. We want to underline, once more, how important is the optimal suppression of physiologic myocardial glucose utilization with (1) high fat, low carbohydrate diet for at least two meals with a fast of at least 4 h prior imaging [24, 30•] ; (2) possible use of intravenous unfractionated heparin (50 IU/kg) approximately 15 min prior to 18 F-FDG injection [16, 31] . In addition, we also recommend to withdraw of metformin which is associated with intense and diffuse [ [5] .
Of note, neither diabetes nor hyperglycemia at the time of the study seems to increase the false-negative rate; a blood glucose level below 200 mg/dL might be suggested [32] . At this stage, there is no evidence to routinely recommend antimicrobial treatment discontinuation before performing [ 18 F]FDG PET/CT. However, the use of antimicrobial should be taken into account during imaging interpretation since they might affect the intensity of FDG uptake due to their immunomodulatory effect [7] . Late PET/CT imaging (2-3 h after FDG injection) should be considered in patients when negative 1-h PET/Ct scan in maximizing the contrast between septic foci and background [33] .
As compared to [
18 F]FDG PET/CT, radiolabelled leukocyte imaging is more time consuming, necessitates in-house leukocytes labelling with direct handling of blood products, requiring specific experience (and should be performed in trained centres) [19, 32•, 34•] . As for [
18 F]FDG PET, the major goals of radiolabelled leukocytes SPECT/CT are to minimize tracer uptake in normal tissues, while maintaining uptake in target tissues. False positive findings have been described in distant septic embolisms (cold spot in spleen/kidney embolism or spondylodiskitis; hot spot in benign or malign process) but not in cardiac infection [14] . False negative scans have been observed (1) in patients with small valve vegetation (<6 mm, limit of spatial resolution), (2) in case of IE by some strains Fig. 4 Proposed algorithm incorporating nuclear imaging and current guidelines in diagnosis IE [1, 6••] (Staphylococcus epidermidis, Enterococcus, Candida, Coxiella burnetii) able to form a biofilm limiting neutrophil recruitment at the primary site of IE and the local efficacy of antimicrobial treatment, (3) in case of drained abscess [14, 32•] . Of note, the impact of antibiotic therapy has not been specifically examined.
Perspectives and Future Developments
The ideal molecular imaging modality would allow for a reliable detection of infection at an early stage, differentiate infection from other causes of inflammation, provide species (causative micro-organism) and resistance information to guide optimal therapy and monitor disease progression, contribute to shorten the hospital stay, prevent clinical complications, and reduce the cost of hospitalization. Such an imaging modality would require discovery of pathogenic mechanisms that can serve as imaging targets (i.e. fibrin, platelet, granulocytes, etc.), development and validation of new pathogen-specific probes (bacteria-targeted imaging approaches), and implementation of technologies that are capable of specific IE detection (targeted molecular imaging), combine molecular imaging to anatomical imaging with high soft-tissue contrast such as PET/ MRI (magnetic resonance imaging) and/or providing detectors with higher sensitivity and spatial resolution (i.e. digital PET/ CT and cadium-zinc-telluride camera) [35, 36] .
Conclusion
Functional nuclear imaging has gained growing interest in the diagnosis and m anagement of IE (Fig. 4 ) . Radiolabelled leukocyte SPECT/CT seems to be more specific for the detection of IE and infectious foci than 18 F-FDG [
18 F]FDG PET/CT. Nevertheless, [ 18 F]FDG PET/CT is likely the preferred first-line metabolic imaging technique since SPECT/CT is less sensitive, more time consuming and require in-house leukocyte labelling. Radiolabelled leukocytes could be reserved for doubtful cases with PET/CT. Nonetheless, radiolabelled leukocytes could be particularly useful in early post-operative period and in NVE. Further research should focus on defining the best protocol and the ideal timing for image acquisition and on the development of more specific probes.
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